J. Soh

J. Soh, S. Toyooka, T. Mitsudomi, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Comparison of PD-L1 Expression Status between Pure-Solid Versus Part-Solid Lung Adenocarcinomas

J. Soh, T. Mitsudomi, S. Shimizu, 2019, Biomolecules.

Non-BAC Component but not Epidermal Growth Factor Receptor Gene Mutation is Associated with Poor Outcomes in Small Adenocarcinoma of the Lung

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Presence of a Ground-Glass Opacity Component Is the True Prognostic Determinant in Clinical Stage I NSCLC

J. Soh, T. Mitsudomi, T. Koga, 2022, JTO clinical and research reports.

Is Surgery after Chemoradiotherapy Feasible in Lung Cancer Patients with Superior Vena Cava Invasion?

J. Soh, S. Toyooka, K. Kiura, 2018, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.

J. Soh, S. Toyooka, S. Miyoshi, 2015, Interactive cardiovascular and thoracic surgery.

Prognostic implications of preoperative versus postoperative circulating tumor DNA in surgically resected lung cancer patients: a pilot study.

J. Soh, T. Mitsudomi, K. Nishio, 2020, Translational lung cancer research.

Perioperative Treatment for the Eradication of Non-small Cell Lung Cancer

J. Soh, T. Mitsudomi, A. Hamada, 2020, Haigan.

Induction chemoradiotherapy using docetaxel and cisplatin with definitive-dose radiation followed by surgery for locally advanced non-small cell lung cancer.

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2017, Journal of thoracic disease.

Frequent EGFR Mutations and Better Prognosis in Positron Emission Tomography-Negative, Solid-Type Lung Cancer.

J. Soh, T. Mitsudomi, A. Hamada, 2021, Clinical lung cancer.

Association between Histological Types and Enhancement of Dynamic CT for Primary Lung Cancer.

J. Soh, S. Toyooka, S. Kanazawa, 2020, Acta Medica Okayama.

Advantage of Induction Chemoradiotherapy for Lung Cancer in Securing Cancer-Free Bronchial Margin.

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2017, The Annals of thoracic surgery.

Extended sleeve lobectomy after induction chemoradiotherapy for non-small cell lung cancer

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2015, Surgery Today.

Anti-tumor effect of neratinib against lung cancer cells harboring HER2 oncogene alterations

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2019, Oncology letters.

A Simple Prognostic Benefit Scoring System for Sarcoma Patients with Pulmonary Metastases: Sarcoma Lung Metastasis Score

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2020, Annals of Surgical Oncology.

Distant Bystander Effect of REIC/DKK3 Gene Therapy Through Immune System Stimulation in Thoracic Malignancies.

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2017, Anticancer research.

Application of amplicon-based targeted sequencing with the molecular barcoding system to detect uncommon minor EGFR mutations in patients with treatment-naïve lung adenocarcinoma

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2019, BMC Cancer.

Establishment and molecular characterization of cell lines from Japanese patients with malignant pleural mesothelioma.

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2016, Oncology letters.

Detection of codon 61 point mutations of the K-ras gene in lung and colorectal cancers by enriched PCR.

J. Soh, S. Toyooka, M. Yano, 2003, Oncology Report.

Risk Factors for Recurrence and Unfavorable Prognosis in Patients with Stage I Non-small Cell Lung Cancer and a Tumor Diameter of 20 mm or Less

J. Soh, S. Toyooka, M. Aoe, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Sequential Molecular Changes during Multistage Pathogenesis of Small Peripheral Adenocarcinomas of the Lung

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Validity of using lobe-specific regional lymph node stations to assist navigation during lymph node dissection in early stage non-small cell lung cancer patients

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2014, Surgery Today.

Detection of EGFR Gene Mutations Using the Wash Fluid of CT-Guided Biopsy Needle in NSCLC Patients

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

DNA methylation status of REIC/Dkk-3 gene in human malignancies

N. Taira, J. Soh, S. Toyooka, 2012, Journal of Cancer Research and Clinical Oncology.

DNA copy number gains in malignant pleural mesothelioma.

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2015, Oncology letters.

One-step nucleic acid amplification for intraoperative diagnosis of lymph node metastasis in lung cancer patients: a single-center prospective study

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2022, Scientific reports.

A case of pancreatic adenocarcinoma with novel K-ras mutation and long term survival

J. Soh, S. Toyooka, K. Tsukuda, 2002, American Journal of Gastroenterology.

A case of pancreatic adenocarcinoma with novel K-ras mutation and long term survival.

J. Soh, S. Toyooka, K. Tsukuda, 2002 .

Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer.

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2017, Oncology letters.

YES1 activation induces acquired resistance to neratinib in HER2‐amplified breast and lung cancers

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2019, Cancer Science.

Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2017, PloS one.

Salvage surgery after definitive chemoradiotherapy for patients with non-small cell lung cancer

J. Soh, T. Mitsudomi, A. Hamada, 2020, Translational lung cancer research.

Fibrosis or Necrosis in Resected Lymph Node Indicate Metastasis Before Chemoradiotherapy in Lung Cancer Patients

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2020, AntiCancer Research.

Pulmonary aspergillosis as a late complication after surgery for locally advanced non-small cell lung cancer treated with induction chemoradiotherapy

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2020, Surgery Today.

Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2018, Oncogenesis.

Long-term spontaneous remission with active surveillance in IgG4-related pleuritis: A case report and literature review

J. Soh, S. Toyooka, K. Kiura, 2019, Respiratory medicine case reports.

The degree of microRNA-34b/c methylation in serum-circulating DNA is associated with malignant pleural mesothelioma.

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2013, Lung cancer.

Density of tumor-infiltrating FOXP3+ T cells as a response marker for induction chemoradiotherapy and a potential prognostic factor in patients treated with trimodality therapy for locally advanced non-small cell lung cancer.

J. Soh, S. Toyooka, S. Miyoshi, 2014, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

Frequent p16 inactivation by homozygous deletion or methylation is associated with a poor prognosis in Japanese patients with pleural mesothelioma.

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2008, Lung cancer.

Takotsubo cardiomyopathy associated with pulmonary resections after induction chemoradiotherapy for non-small cell lung cancer

J. Soh, S. Toyooka, S. Miyoshi, 2012, General Thoracic and Cardiovascular Surgery.

Fever after lung radiofrequency ablation: Prospective evaluation of its incidence and associated factors.

J. Soh, S. Toyooka, K. Kiura, 2015, European journal of radiology.

Foretinib can overcome common on-target resistance mutations after capmatinib/tepotinib treatment in NSCLCs with MET exon 14 skipping mutation

J. Soh, T. Mitsudomi, T. Koga, 2022, Journal of Hematology & Oncology.

Use of a vessel sealing system versus conventional electrocautery for lung parenchymal resection: a comparison of the clinicopathological outcomes in porcine lungs

J. Soh, S. Toyooka, S. Miyoshi, 2014, Surgery Today.

Alterations in Genes of the EGFR Signaling Pathway and Their Relationship to EGFR Tyrosine Kinase Inhibitor Sensitivity in Lung Cancer Cell Lines

Michael Peyton, John D. Minna, Yang Xie, 2009, PloS one.

Propensity score analysis for the efficacy of preoperative antibiotics in patients with resected primary lung cancer: Levofloxacin versus cefazolin

J. Soh, T. Mitsudomi, S. Fukuda, 2022, Clinical Surgical Oncology.

Intrathoracic irrigation with arbekacin for methicillin-resistant Staphylococcus aureus empyema following lung resection.

J. Soh, S. Toyooka, S. Miyoshi, 2012, Interactive cardiovascular and thoracic surgery.

Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer

J. Minna, A. Gazdar, J. Soh, 2013, Oncogene.

Newly developed anti‐S100A8/A9 monoclonal antibody efficiently prevents lung tropic cancer metastasis

J. Soh, S. Toyooka, Hiroki Sato, 2018, International journal of cancer.

exSSSRs (extracellular S100 soil sensor receptors)‐Fc fusion proteins work as prominent decoys to S100A8/A9‐induced lung tropic cancer metastasis

J. Soh, S. Toyooka, Hiroki Sato, 2018, International journal of cancer.

Hsp 90 inhibitor NVP-AUY 922 enhances the radiation sensitivity of lung cancer cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors

J. Soh, S. Toyooka, S. Miyoshi, 2015 .

The impact and role of EGFR gene mutation on non-small cell lung cancer

J. Soh, S. Toyooka, H. Shigematsu, 2006, Cancer Chemotherapy and Pharmacology.

Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR‐TKIs in non‐small cell lung cancer

Hirokuni Ikeda, J. Soh, S. Toyooka, 2018, Cancer science.

Molecular oncology of lung cancer

J. Soh, S. Toyooka, S. Miyoshi, 2011, General thoracic and cardiovascular surgery.

Molecular biology of lung cancer

J. Soh, S. Toyooka, S. Miyoshi, 2010 .

Acquired resistance to EGFR inhibitors is associated with a manifestation of stem cell-like properties in cancer cells.

W. Lam, J. Soh, S. Toyooka, 2013, Cancer research.

Oncogene Mutations, Copy Number Gains and Mutant Allele Specific Imbalance (MASI) Frequently Occur Together in Tumor Cells

Calum MacAulay, John D. Minna, David S. Shames, 2009, PloS one.

CDKN2A/p16 Inactivation Mechanisms and Their Relationship to Smoke Exposure and Molecular Features in Non–Small-Cell Lung Cancer

Michael Q. Zhang, Wei Zhang, Xiaotu Ma, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

KRAS secondary mutations that confer acquired resistance to KRAS G12C inhibitors, sotorasib and adagrasib, and overcoming strategies: insights from the in vitro experiments.

J. Soh, T. Mitsudomi, T. Arita, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Epigenetic Silencing of MicroRNA-34b/c Plays an Important Role in the Pathogenesis of Malignant Pleural Mesothelioma

J. Soh, S. Toyooka, S. Miyoshi, 2011, Clinical Cancer Research.

Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features

J. Soh, S. Toyooka, S. Miyoshi, 2017, Scientific Reports.

Intra-tumor and Inter-tumor Heterogeneity in MET Exon 14 Skipping Mutations and Co-mutations in Pulmonary Pleomorphic Carcinomas.

J. Soh, T. Mitsudomi, K. Nishio, 2021, Clinical lung cancer.

Activity and mechanism of acquired resistance to tarloxotinib in HER2 mutant lung cancer: an in vitro study

J. Soh, T. Mitsudomi, R. Doebele, 2021, Translational lung cancer research.

Optimal method for quantitative detection of plasma EGFR T790M mutation using droplet digital PCR system.

J. Soh, S. Toyooka, S. Miyoshi, 2017, Oncology reports.

Genetic predictors of MEK dependence in non-small cell lung cancer.

William Pao, Barry S Taylor, Neal Rosen, 2008, Cancer research.

In vitro validation study of HER2 and HER4 mutations identified in an ad hoc secondary analysis of the LUX-Lung 8 randomized clinical trial.

J. Soh, T. Mitsudomi, T. Koga, 2021, Lung cancer.

CDKN 2 A / p 16 Inactivation Mechanisms and Their Relationship to Smoke Exposure and Molecular Features in Non – Small-Cell Lung Cancer

Michael Q. Zhang, S. Hanash, W. Lam, 2013 .

Aberrant methylation of p21 gene in lung cancer and malignant pleural mesothelioma.

Hiroaki Asano, Kazunori Tsukuda, J. Soh, 2011, Acta medica Okayama.

The allelic distribution of a single nucleotide polymorphism in the PDCD5 gene locus of Japanese non-small cell lung cancer patients.

J. Soh, S. Toyooka, K. Matsuo, 2008, Molecular medicine reports.

Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy

J. Minna, J. Soh, L. Girard, 2011, Molecular Cancer Therapeutics.

Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non–Small Cell Lung Cancer Cells

J. Soh, S. Toyooka, Hiroki Sato, 2018, Molecular Cancer Research.

Hereditary Lung Cancer Syndrome Targets Never Smokers with Germline EGFR Gene T790M Mutations

J. Soh, S. Toyooka, W. Travis, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Downregulation of microRNA-34 induces cell proliferation and invasion of human mesothelial cells.

J. Soh, S. Toyooka, S. Miyoshi, 2013, Oncology reports.

TAE226, a Bis-Anilino Pyrimidine Compound, Inhibits the EGFR-Mutant Kinase Including T790M Mutant to Show Anti-Tumor Effect on EGFR-Mutant Non-Small Cell Lung Cancer Cells

J. Soh, S. Toyooka, S. Miyoshi, 2015, PloS one.

Comprehensive analysis of EGFR signaling pathways in Japanese patients with non-small cell lung cancer.

J. Soh, S. Toyooka, Masaki Tokumo, 2009, Lung cancer.

Droplet digital PCR as a novel system for the detection of microRNA‑34b/c methylation in circulating DNA in malignant pleural mesothelioma.

J. Soh, S. Toyooka, Hiroki Sato, 2019, International journal of oncology.

Histone Deacetylase Inhibitor Romidepsin Enhances Anti-Tumor Effect of Erlotinib in Non-small Cell Lung Cancer (NSCLC) Cell Lines

J. Minna, J. Soh, M. Peyton, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Diagnostic Value of Dual-time-point F-18 FDG PET/CT and Chest CT for the Prediction of Thymic Epithelial Neoplasms.

J. Soh, S. Toyooka, S. Miyoshi, 2017, Acta medica Okayama.

Perioperative Therapy for Non-Small Cell Lung Cancer with Immune Checkpoint Inhibitors

J. Soh, T. Mitsudomi, A. Hamada, 2021, Cancers.

Adjuvant therapy of operable nonsmall cell lung cancer: an update

J. Soh, T. Mitsudomi, 2020, Current opinion in oncology.

Prognostic nutrition index affects the prognosis of patients undergoing trimodality therapy for locally advanced non-small cell lung cancer

J. Soh, S. Toyooka, K. Kiura, 2020, Surgery Today.

EGFR mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma

J. Soh, S. Toyooka, K. Matsuo, 2009 .

Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib‐treated patients with lung adenocarcinoma

J. Soh, S. Toyooka, K. Matsuo, 2008, Cancer science.

Clinical Significance of Epidermal Growth Factor Receptor Gene Mutations on Treatment Outcome after First-line Cytotoxic Chemotherapy in Japanese Patients with Non-small Cell Lung Cancer

J. Soh, S. Toyooka, K. Kiura, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer

J. Soh, S. Toyooka, K. Kiura, 2006, International journal of cancer.

MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors

W. Lam, J. Minna, J. Soh, 2009, International journal of cancer.

ERCC1 protein expression predicts the response of cisplatin-based neoadjuvant chemotherapy in non-small-cell lung cancer.

J. Soh, S. Toyooka, K. Kiura, 2008, Lung cancer.

Usefulness of Thoracoscopic Debridement for Chronic Empyema after an Extrapleural Pneumonectomy.

J. Soh, S. Toyooka, S. Miyoshi, 2016, Acta medica Okayama.

Strong anti-tumor effect of NVP-AUY922, a novel Hsp90 inhibitor, on non-small cell lung cancer.

J. Soh, S. Toyooka, S. Miyoshi, 2012, Lung cancer.

Prognostic implications of preoperative versus postoperative circulating tumor DNA in surgically resected lung cancer patients: a pilot study

J. Soh, T. Mitsudomi, K. Nishio, 2020, Translational lung cancer research.

Critical role of the MCAM-ETV4 axis triggered by extracellular S100A8/A9 in breast cancer aggressiveness

J. Soh, S. Toyooka, Hiroki Sato, 2019, Neoplasia.

Antitumor activity of pan‐HER inhibitors in HER2‐positive gastric cancer

J. Soh, S. Toyooka, K. Tsukuda, 2018, Cancer science.

The Impact of Sex and Smoking Status on the Mutational Spectrum of Epidermal Growth Factor Receptor Gene in Non–small Cell Lung Cancer

J. Soh, S. Toyooka, I. Wistuba, 2007, Clinical Cancer Research.

The prognostic nutritional index is correlated negatively with the lung allocation score and predicts survival after both cadaveric and living-donor lobar lung transplantation

J. Soh, S. Toyooka, M. Okazaki, 2021, Surgery Today.

Contralateral pneumothorax in bullous lung after pneumonectomy: report of two cases

J. Soh, S. Toyooka, S. Miyoshi, 2012, General Thoracic and Cardiovascular Surgery.

Hsp90 inhibitor NVP-AUY922 enhances the radiation sensitivity of lung cancer cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors.

J. Soh, S. Toyooka, S. Miyoshi, 2015, Oncology reports.

Drug resistance to EGFR tyrosine kinase inhibitors for non-small cell lung cancer.

J. Soh, S. Toyooka, S. Miyoshi, 2014, Acta medica Okayama.

Mechanisms and Overcome of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors

J. Soh, S. Toyooka, S. Miyoshi, 2012 .

The anti-proliferative effect of heat shock protein 90 inhibitor, 17-DMAG, on non-small-cell lung cancers being resistant to EGFR tyrosine kinase inhibitor.

J. Soh, S. Toyooka, S. Miyoshi, 2012, Lung cancer.

Effectiveness of scheduled intravenous acetaminophen in the postoperative pain management of video-assisted thoracic surgery

J. Soh, S. Toyooka, K. Shien, 2020, Surgery Today.

Ethnicity affects EGFR and KRAS gene alterations of lung adenocarcinoma.

S. Lam, J. Soh, S. Toyooka, 2015, Oncology letters.

Dose-dependence in acquisition of drug tolerant phenotype and high RYK expression as a mechanism of osimertinib tolerance in lung cancer.

J. Soh, T. Mitsudomi, T. Koga, 2021, Lung cancer.

Acquisition of cancer stem cell-like properties in non-small cell lung cancer with acquired resistance to afatinib

J. Soh, S. Toyooka, S. Miyoshi, 2015, Cancer science.

Silenced expression of NFKBIA in lung adenocarcinoma patients with a never-smoking history.

J. Soh, S. Toyooka, S. Miyoshi, 2013, Acta medica Okayama.

Tumor-suppressive effect of LRIG1, a negative regulator of ErbB, in non-small cell lung cancer harboring mutant EGFR

J. Soh, S. Toyooka, S. Miyoshi, 2018, Carcinogenesis.

Tumor-suppressive effect of LRIG 1 in lung cancer

J. Soh, S. Toyooka, S. Miyoshi, 2022 .

The impact of epidermal growth factor receptor gene status on gefitinib‐treated Japanese patients with non‐small‐cell lung cancer

J. Soh, S. Toyooka, Masaki Tokumo, 2007, International journal of cancer.

Impact of GLUT1 and Ki-67 expression on early‑stage lung adenocarcinoma diagnosed according to a new international multidisciplinary classification.

J. Soh, S. Toyooka, S. Miyoshi, 2013, Oncology reports.

Elevated serum level of sialylated glycoprotein KL-6 predicts a poor prognosis in patients with non-small cell lung cancer treated with gefitinib.

J. Soh, S. Toyooka, K. Kiura, 2008, Lung cancer.

Impact of HER2 and EGFR gene status on gefitinib‐treated patients with nonsmall‐cell lung cancer

J. Soh, S. Toyooka, K. Kiura, 2007, International journal of cancer.

EGFR mutation status in pleural fluid predicts tumor responsiveness and resistance to gefitinib.

J. Soh, S. Toyooka, K. Kiura, 2007, Lung cancer.

Surgical therapy for pulmonary metastasis of breast cancer

J. Soh, T. Mitsudomi, Y. Komoike, 2020, Translational cancer research.

Genetic alterations in lung adenocarcinoma with a micropapillary component.

J. Soh, S. Toyooka, S. Miyoshi, 2016, Molecular and clinical oncology.

Antitumor effect of afatinib , as a HER 2-targeted therapy , in lung cancers harboring HER 2 oncogene alterations

J. Soh, S. Toyooka, S. Miyoshi, 2015 .

Anti-Cancer Effects of REIC/Dkk-3-encoding Adenoviral Vector for the Treatment of Non-small Cell Lung Cancer

J. Soh, S. Toyooka, S. Miyoshi, 2014, PloS one.

Antitumor effect of afatinib, as a human epidermal growth factor receptor 2‐targeted therapy, in lung cancers harboring HER2 oncogene alterations

J. Soh, S. Toyooka, S. Miyoshi, 2015, Cancer Science.

Impact of age on epidermal growth factor receptor mutation in lung cancer.

J. Soh, S. Toyooka, S. Miyoshi, 2012, Lung cancer.

Presence of EGFR mutation in pathologically non-malignant specimens from computed tomography-guided lung needle biopsies.

J. Soh, S. Toyooka, S. Miyoshi, 2012, Oncology letters.

DV200 Index for Assessing RNA Integrity in Next-Generation Sequencing

J. Soh, S. Toyooka, S. Tomida, 2020, BioMed research international.

Ganetespib in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-resistant Non-small Cell Lung Cancer

J. Soh, S. Toyooka, T. Shien, 2019, AntiCancer Research.

Presence of the minor EGFR T790M mutation is associated with drug-sensitive EGFR mutations in lung adenocarcinoma patients.

J. Soh, S. Toyooka, S. Miyoshi, 2014, Oncology reports.

Knockdown of the epidermal growth factor receptor gene to investigate its therapeutic potential for the treatment of non-small-cell lung cancers.

J. Soh, S. Toyooka, S. Miyoshi, 2012, Clinical lung cancer.

Open Access Research Article

Hirokuni Ikeda, N. Taira, F. Hara, 2022 .

Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer.

J. Soh, S. Toyooka, S. Miyoshi, 2012, Lung cancer.

Study about the Efficacy of Metformin to Immune Function in Cancer Patients.

J. Soh, S. Toyooka, T. Shien, 2016, Acta medica Okayama.

Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301

J. Soh, S. Toyooka, K. Matsuo, 2021, BMC cancer.

A Multicenter Randomized Controlled Study of Paclitaxel plus Carboplatin versus Oral Uracil‐Tegafur as the Adjuvant Chemotherapy in Resected Non–Small Cell Lung Cancer

J. Soh, S. Toyooka, S. Miyoshi, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Feasibility of adjuvant chemotherapy with S-1 plus carboplatin followed by single-agent maintenance therapy with S-1 for completely resected non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 1001

J. Soh, S. Toyooka, K. Matsuo, 2017, International Journal of Clinical Oncology.

Epidermal growth factor receptor mutation status and adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.

J. Soh, S. Toyooka, K. Matsuo, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Active Secretion of Dimerized S100A11 Induced by the Peroxisome in Mesothelioma Cells

J. Soh, S. Toyooka, M. Sakaguchi, 2016, Cancer Microenvironment.

Adult mesenchymal hamartoma of the chest wall: report of a case.

J. Soh, S. Toyooka, S. Miyoshi, 2014, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy.

J. Soh, S. Toyooka, S. Miyoshi, 2012, Lung cancer.

Pulmonary resection in a prone position for lung cancer invading the spine

J. Soh, S. Toyooka, K. Shien, 2019, General Thoracic and Cardiovascular Surgery.

Ectopic cervical thymoma: a case report with 18F-fluorodeoxyglucose positron emission tomography findings.

Hirokuni Ikeda, N. Taira, J. Soh, 2012, Acta medica Okayama.

Ectopic Cervical Thymoma: A Case Report with 18 F-fluorodeoxyglucose Positron Emission

Hirokuni Ikeda, N. Taira, J. Soh, 2012 .

Primary pulmonary melanoma: a report of two cases

J. Soh, S. Toyooka, S. Miyoshi, 2015, World Journal of Surgical Oncology.

Novel Germline Mutation in the Transmembrane Domain of HER2 in Familial Lung Adenocarcinomas

J. Soh, S. Toyooka, S. Miyoshi, 2013, Journal of the National Cancer Institute.

Impact of pathological stage and histological subtype on clinical outcome of adjuvant chemotherapy of paclitaxel plus carboplatin versus oral uracil–tegafur for non-small cell lung cancer: subanalysis of SLCG0401 trial

J. Soh, S. Toyooka, M. Aoe, 2019, International Journal of Clinical Oncology.

Resection of the entire first rib for fibrous dysplasia using a combined posterior-transmanubrial approach

J. Soh, S. Toyooka, S. Miyoshi, 2012, General Thoracic and Cardiovascular Surgery.

The neutrophil-to-lymphocyte ratio as a novel independent prognostic factor for multiple metastatic lung tumors from various sarcomas

J. Soh, S. Toyooka, K. Shien, 2020, Surgery Today.

Impact of aberrant methylation of microRNA-9 family members on non-small cell lung cancers.

J. Soh, S. Toyooka, S. Miyoshi, 2013, Molecular and clinical oncology.

Early postoperative complications after middle lobe-preserving surgery for secondary lung cancer

J. Soh, S. Toyooka, S. Miyoshi, 2017, Surgery Today.

Bronchoplasty to adjust mismatches in the proximal and distal bronchial stumps during bronchial sleeve resection of the left lower lobe and lingular division.

J. Soh, S. Toyooka, S. Miyoshi, 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Sacrificing the pulmonary arterial branch to the spared lobe is a risk factor of bronchopleural fistula in sleeve lobectomy after chemoradiotherapy.

J. Soh, S. Toyooka, S. Miyoshi, 2013, European Journal of Cardio-Thoracic Surgery.

Radiofrequency Ablation of Lung Tumors Using a Multitined Expandable Electrode: Impact of the Electrode Array Diameter on Local Tumor Progression.

J. Soh, S. Toyooka, S. Kanazawa, 2016, Journal of vascular and interventional radiology : JVIR.

Therapeutic strategies for afatinib‐resistant lung cancer harboring HER2 alterations

J. Soh, S. Toyooka, S. Miyoshi, 2018, Cancer science.

Melanoma cell adhesion molecule is the driving force behind the dissemination of melanoma upon S100A8/A9 binding in the original skin lesion.

J. Soh, S. Toyooka, Kaori Sasai, 2019, Cancer letters.

Continuing surgical education of non-technical skills

J. Soh, S. Toyooka, T. Yorifuji, 2020, Annals of medicine and surgery.

Inter- and Intratumor Heterogeneity of EGFR Compound Mutations in Non-Small Cell Lung Cancers: Analysis of Five Cases.

J. Soh, T. Mitsudomi, K. Nishio, 2020, Clinical lung cancer.

Prognostic value of plasma fibrinogen and d-dimer levels in patients with surgically resected non-small cell lung cancer

J. Soh, T. Mitsudomi, T. Koga, 2020, Surgery Today.

Neuroplastin‐β mediates S100A8/A9‐induced lung cancer disseminative progression

J. Soh, S. Toyooka, M. Sakaguchi, 2019, Molecular carcinogenesis.

Restrictive ventilatory impairment is associated with poor outcome in patients with cT1aN0M0 peripheral squamous cell carcinoma of the lung.

J. Soh, S. Toyooka, S. Miyoshi, 2017, Journal of thoracic disease.

Dose-Volume Parameters Predict Radiation Pneumonitis after Surgery with Induction Concurrent Chemoradiotherapy for Non-small Cell Lung Cancer.

J. Soh, S. Toyooka, K. Kiura, 2018, Acta medica Okayama.

MicroRNA miR-34b/c enhances cellular radiosensitivity of malignant pleural mesothelioma cells.

J. Soh, S. Toyooka, S. Miyoshi, 2012, Anticancer research.

Chemoradiation therapy for non-small cell lung cancer exacerbates thoracic aortic calcification determined by computed tomography

J. Soh, S. Toyooka, K. Kiura, 2020, Heart and Vessels.

Myoepithelioma occurring in the posterior mediastinum harboring EWSR1 rearrangement: a case report.

J. Soh, S. Toyooka, K. Shien, 2018, Japanese journal of clinical oncology.

Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis

J. Soh, S. Toyooka, K. Kiura, 2019, BMC Cancer.

Preclinical evaluation of microRNA-34b/c delivery for malignant pleural mesothelioma.

J. Soh, S. Toyooka, S. Miyoshi, 2014, Acta medica Okayama.

P2.03-20 Potent in Vitro Activity of Tarloxotinib for HER2 Exon 20 Mutations in Lung Cancer and Mechanism of Acquired Resistance

J. Soh, V. Tirunagaru, T. Koga, 2019, Journal of Thoracic Oncology.

Abstract 724: Anti-tumor effect of Dasatinib in HER2 positive breast cancer with Trastuzumab resistance

J. Soh, S. Toyooka, S. Miyoshi, 2015 .

Effects of Cold Ischemia on RNA Stability and Quality of Lung Tissues Based on Standard PREanalytical Code Categorization.

J. Soh, S. Toyooka, S. Tomida, 2017, Biopreservation and Biobanking.

Prognostic role of preoperative fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography with an image-based harmonization technique: A multicenter retrospective study

J. Soh, J. Usuda, T. Mitsudomi, 2023, JTCVS open.

The impact of EGFR mutation and smoking status on non-small-cell lung cancer patients treated with geftinib: A5-04

J. Soh, S. Toyooka, Y. Yatabe, 2007 .

Long-term outcomes of pneumonectomy, back-table lung preservation, double-sleeve resection and reimplantation for advanced central lung cancer: the Oto procedure.

J. Soh, S. Sugimoto, T. Oto, 2019, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Induction Chemoradiotherapy Followed by Surgical Resection for Clinical T3 or T4 Locally Advanced Non–Small Cell Lung Cancer

J. Soh, S. Toyooka, S. Miyoshi, 2012, Annals of Surgical Oncology.

Randomized feasibility study of S-1 for adjuvant chemotherapy in completely resected Stage IA non–small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 0701

J. Soh, S. Toyooka, K. Matsuo, 2016, Japanese journal of clinical oncology.

Survival Outcomes of Treatment with Radiofrequency Ablation, Stereotactic Body Radiotherapy, or Sublobar Resection for Patients with Clinical Stage I Non-Small-Cell Lung Cancer: A Single-Center Evaluation.

J. Soh, S. Toyooka, S. Kanazawa, 2020, Journal of vascular and interventional radiology : JVIR.

Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm)—IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group Study 1201

J. Soh, S. Toyooka, K. Matsuo, 2023, PloS one.

Chronic lung injury after trimodality therapy for locally advanced non-small cell lung cancer.

J. Soh, S. Toyooka, K. Kiura, 2020, The Annals of thoracic surgery.

A Multicenter Randomized Controlled Study of Paclitaxel plus Carboplatin versus Oral Uracil-Tegafur as the Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer

J. Soh, S. Toyooka, S. Miyoshi, 2018 .

Lower lobe origin is a poor prognostic factor in locally advanced non-small-cell lung cancer patients treated with induction chemoradiotherapy.

J. Soh, S. Toyooka, S. Miyoshi, 2015, Molecular and clinical oncology.

Trimodality therapy consisting of induction chemoradiotherapy (CRT) followed by surgery is a potential treatment option for locally advanced non-small-cell lung cancer (NSCLC). Two randomized phase III trials investigated the prognostic effect of surgery following induction CRT in patients with medi

J. Soh, S. Toyooka, S. Miyoshi, 2015 .

Second primary cancer in survivors of locally advanced non-small cell lung cancer treated with concurrent chemoradiation followed by surgery

J. Soh, S. Toyooka, K. Kiura, 2018, Japanese journal of clinical oncology.

A Case of Carcinoma Showing Thymus-Like Differentiation with a Rapidly Lethal Course

N. Taira, J. Soh, S. Toyooka, 2014, Case Reports in Oncology.

Massive Subcutaneous and Mediastinal Emphysema with Little Pneumothorax Treated by Surgery after Pulmonary Radiofrequency Ablation

J. Soh, S. Toyooka, S. Miyoshi, 2014, CardioVascular and Interventional Radiology.

Comparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysis

J. Soh, S. Toyooka, S. Tomida, 2018, Cancer science.

Induction S-1+Concurrent Radiotherapy Followed by Surgical Resection of Locally Advanced Non-small-cell Lung Cancer in an Elderly Patient.

J. Soh, S. Toyooka, S. Miyoshi, 2016, Acta Medica Okayama.

Predicting pleural invasion using HRCT and 18F-FDG PET/CT in lung adenocarcinoma with pleural contact

J. Soh, S. Toyooka, S. Miyoshi, 2015, Annals of Nuclear Medicine.

Acquired resistance mechanisms to afatinib in HER2‐amplified gastric cancer cells

J. Soh, S. Toyooka, S. Tomida, 2019, Cancer science.

MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors

W. Lam, J. Minna, J. Soh, 2009, International journal of cancer.

The degree of microRNA-34b/c methylation in serum-circulating DNA is associated with malignant pleural mesothelioma.

J. Soh, S. Toyooka, S. Miyoshi, 2013, Lung cancer.

Epigenetic Silencing of MicroRNA-34b/c Plays an Important Role in the Pathogenesis of Malignant Pleural Mesothelioma

J. Soh, S. Toyooka, S. Miyoshi, 2011, Clinical Cancer Research.

Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer.

J. Soh, S. Toyooka, S. Miyoshi, 2012, Lung cancer.

Hereditary Lung Cancer Syndrome Targets Never Smokers with Germline EGFR Gene T790M Mutations

J. Soh, S. Toyooka, W. Travis, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Prognostic role of preoperative fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography with an image-based harmonization technique: A multicenter retrospective study

J. Soh, J. Usuda, T. Mitsudomi, 2023, JTCVS open.

A Giant Thymic Cyst Accompanied by Acute Mediastinitis.

J. Soh, S. Toyooka, K. Shien, 2020, Acta medica Okayama.

Radiofrequency ablation of pulmonary metastases from sarcoma: single-center retrospective evaluation of 46 patients

J. Soh, S. Toyooka, S. Kanazawa, 2017, Japanese Journal of Radiology.

Clinical outcome of patients with recurrent non-small cell lung cancer after trimodality therapy

J. Soh, S. Toyooka, S. Miyoshi, 2019, Surgery Today.

The Feasibility of Median Sternotomy With or Without Thoracotomy for Locally Advanced Non-Small Cell Lung Cancer Treated With Induction Chemoradiotherapy.

J. Soh, S. Toyooka, S. Miyoshi, 2016, The Annals of thoracic surgery.

EGFR Mutation is a Prognostic Factor in Lung Cancer Patients with Pleural Dissemination Detected During or After Surgery

J. Soh, S. Toyooka, K. Shien, 2023, Annals of Surgical Oncology.